logo

1.48

1.48 (-2.18%)

As of May 31, 2023

Tcr2 Therapeutics Inc. [TCRR]

Source: 

Company Overview

Tcr2 Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for cancer patients suffering from solid tumors by powering the T cell receptor with our proprietary, first-in-class TCR Fusion Construct T cells.

CountryUnited States
Headquarterscambridgemassachusetts
Phone Number617-949-5200
Industry
manufacturing
CEOGarry E. Menzel
Websitewww.tcr2.com